MedPath

Impact of Salpingectomy on Ovarian Reserve

Not Applicable
Completed
Conditions
Laparoscopic Salpingectomy
Interventions
Device: Bipolar electric energy
Device: ultrasound energy
Registration Number
NCT02284711
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

Epithelial cancer of the ovaries is the most severe form of gynecologic cancer; a significant proportion of ovarian cancers originate from the Fallopian tube. Guidelines therefore now recommend systematically associating prophylactic salpingectomy to benign hysterectomy. The principal objective of the present study is to assess the impact of salpingectomy on ovarian reserve by anti-Müllerian hormone (AMH) assay and calculating the Doppler index of vascular resistance in the ovarian vessels. The secondary objective is to compare ovarian reserve results between two coagulation techniques used in salpingectomy: bipolar electric energy versus ultrasound.

The study design is single-center, prospective, before-and-after, with open randomization between two groups defined by coagulation technique.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
96
Inclusion Criteria
  • Female subjects aged 18
  • Scheduled surgery: bilateral laparoscopic salpingectomy associated to hysterectomy for benign indication
Exclusion Criteria
  • Interview revealing disorder entailing unacceptable risk of postoperative complications: coagulation disorder, immune system disorder, evolutive disease, etc.
  • Pregnancy, ongoing or planned during the study period
  • History of bilateral salpingectomy
  • Salpingectomy associated with pelvic cancer
  • Oral hormonal contraception during the study period
  • Menopause
  • Inability to understand information provided
  • Not covered by a national health insurance scheme, prisoner or under administrative supervision.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
BipolarBipolar electric energyCoagulation during salpingectomy using conventional bipolar electric energy
Ultrasoundultrasound energyCoagulation during salpingectomy using UltraCision HARMONIC ACE® ultrasound energy
Primary Outcome Measures
NameTimeMethod
AMH level3 months post-surgery
Secondary Outcome Measures
NameTimeMethod
menopausal quality of life score1 and 3 months post-surgery
index of vascular resistance in the ovarian vessels1 and 3 months post-surgery
AMH level1 month post-surgery

Trial Locations

Locations (1)

Hospices Civils de Lyon - HFME

🇫🇷

Lyon, France

© Copyright 2025. All Rights Reserved by MedPath